Your browser doesn't support javascript.
loading
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.
Martini, Alberto; Jia, Rachel; Ferket, Bart S; Waingankar, Nikhil; Plimack, Elizabeth R; Crabb, Simon J; Harshman, Lauren C; Yu, Evan Y; Powles, Thomas; Rosenberg, Jonathan E; Pal, Sumanta K; Vaishampayan, Ulka N; Necchi, Andrea; Wiklund, N Peter; Mehrazin, Reza; Mazumdar, Madhu; Sfakianos, John P; Galsky, Matthew D.
Afiliação
  • Martini A; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Jia R; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Ferket BS; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Waingankar N; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Plimack ER; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Crabb SJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Harshman LC; University of Southampton, Southampton, United Kingdom.
  • Yu EY; Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Powles T; University of Washington, Seattle, Washington.
  • Rosenberg JE; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Pal SK; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Vaishampayan UN; City of Hope Comprehensive Cancer Center, Duarte, California.
  • Necchi A; Karmanos Cancer Center, Wayne State University, Detroit, Michigan.
  • Wiklund NP; National Institute for Tumors, Milan, Italy.
  • Mehrazin R; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Mazumdar M; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Sfakianos JP; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Galsky MD; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.
Cancer ; 125(18): 3155-3163, 2019 09 15.
Article em En | MEDLINE | ID: mdl-31150110
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Cisplatino / Terapia Neoadjuvante / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Cisplatino / Terapia Neoadjuvante / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article